Articles
Amgen/Immunex
Acts as a Carrot For Firms With Big Growth Aspirations
Interview with John Maddox (ex. Vice President)
Published in Mergers
& Acquisitions, March 2002
The
Outlook for Virtual Pharmaceutical Companies
Published in Decision
Resources, Spectrum Life Sciences, June 2001
Sizing
Up Biotech M&A as Industry Dynamics Continue to Change
Interview with John Maddox (ex. Vice President)
Published in Mergers
& Acquisitions, May 2001
From Patents to Franchises:
Emphasis on patents must be supplemented with a willingness to exploit the equity inherent in the brand itself. And that could be going beyond drugs.
Published in IN VIVO, April 2001
When DTC is DOA:
The right marketing mix trumps awareness advertising
Published in Pharmaceutical Executive, April 2001
Innovation, Not Regulation:
Why fewer restrictions on pharmaceutical companies would benefit patients
Published in Healthcare Business, April 2001
Let Marketing Solve the Problem of Drug Affordability
Published in Healthcare Review,
Jan.8-Feb.12, 2001 Volume 14, Issue 1
Jan.15-Feb.19, 2001 Volume 11, Issue 1
The Fight for Patent Rights: Is it time for pharma to move on?
Commentary by Vimal Bahuguna and Robert Lieberman
Published in Scrip Magazine, November 2000
The Myth of Option Pricing
Published in IN VIVO, May 2000
